Shikiar Asset Management Inc Merck & Co., Inc. Transaction History

Shikiar Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$71.77 - $79.65 $373,204 - $414,180	-5,200 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$63.36 - $87.82 $63,360 - $87,820	-1,000 Reduced 16.13%	5,200 $400,000
Q4 2019 Jan 28, 2020	SELL	$77.58 - $87.54 $73,701 - $83,163	-950 Reduced 13.29%	6,200 $564,000
Q3 2019 Oct 29, 2019	SELL	$76.08 - $82.93 $327,144 - $356,599	-4,300 Reduced 37.55%	7,150 $602,000
Q2 2019 Jul 25, 2019	SELL	$69.84 - $81.59 $122,220 - $142,782	-1,750 Reduced 13.26%	11,450 $960,000
Q4 2018 Feb 01, 2019	SELL	$65.24 - $75.71 $65,239 - $75,710	-1,000 Reduced 7.04%	13,200 $1.01 Million
Q2 2018 Jul 27, 2018	SELL	$50.83 - $59.72 $109,284 - $128,398	-2,150 Reduced 13.15%	14,200 $862,000
Q1 2018 Apr 16, 2018	SELL	$50.96 - $59.23 $667,168 - $775,439	-13,092 Reduced 44.47%	16,350 $891,000
Q4 2017 Jan 26, 2018	SELL	$51.62 - $61.64 $25,810 - $30,820	-500 Reduced 1.67%	29,442 $1.66 Million
Q3 2017 Oct 20, 2017	BUY	$58.67 - $63.13 $1.76 Million - $1.89 Million	29,942	29,942 $1.92 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Shikiar Asset Management Inc with notifications on news.